NFKB1 and neoplasm: In addition, many tumor immune pathways were enriched in the low-risk group such as immunoregulatory interactions between a lymphoid and a nonlymphoid cell, fceri mediated NF-KB, PD_1 signaling, adaptive immune system, and fceri mediated MAPK (Figure 6B).